(Q116414307)

English

Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability

scientific article published on 26 July 1975

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability (English)

1 reference

stated in

Crossref

DOI

10.1136/BMJ.3.5977.195

reference URL

https://api.crossref.org/works/10.1136/BMJ.3.5977.195

25 January 2023

1 reference

Europe PubMed Central

PubMed publication ID

238716

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238716

25 January 2023

1 reference

10.1136/BMJ.3.5977.195

reference URL

https://api.crossref.org/works/10.1136/BMJ.3.5977.195

retrieved

25 January 2023

author name string

P. Roy

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

238716

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238716

retrieved

25 January 2023

L. Day

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

238716

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238716

retrieved

25 January 2023

E. Sowton

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

238716

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238716

retrieved

25 January 2023

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

238716

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=238716

retrieved

25 January 2023

publication date

26 July 1975

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

238716

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=238716

retrieved

25 January 2023

full work available at URL

https://europepmc.org/articles/PMC1674130

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

238716

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238716

retrieved

25 January 2023

https://europepmc.org/articles/PMC1674130?pdf=render

file format

Portable Document Format

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

238716

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238716

retrieved

25 January 2023

https://syndication.highwire.org/content/doi/10.1136/bmj.3.5977.195

1 reference

stated in

Crossref

DOI

10.1136/BMJ.3.5977.195

reference URL

https://api.crossref.org/works/10.1136/BMJ.3.5977.195

retrieved

25 January 2023

Identifiers

DOI

10.1136/BMJ.3.5977.195

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

238716

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=238716

25 January 2023

1 reference

National Center for Biotechnology Information

PubMed publication ID

238716

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=238716

retrieved

25 January 2023

PubMed publication ID

238716

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

238716

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=238716

(Q116414307)

Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)